Results 211 to 220 of about 17,787 (263)

Psychotropic Agents in Dermatology

Dermatologic Clinics, 1993
In this article, relatively detailed explanation of the use of selected psychopharmacologic agents is given along with their dermatologic and psychodermatologic indications. For a more complete description of the use of these medications, the reader is advised to consult standard textbooks on psychopharmacology and the Physician's Desk Reference.
openaire   +2 more sources

Cytokine blocking agents in dermatology.

Clinical and experimental dermatology, 2002
Cytokines are intercellular messengers that have an important role in the development and maintenance of cutaneous inflammation. The primacy of cytokines in eliciting cutaneous immune responses makes them a highly attractive target for new biological response modifiers. Targeting of cytokines is still in its infancy for therapy of skin disease. However,
Williams, Jason D L, Griffiths, C. E M
openaire   +2 more sources

Use of the Newer Immunosuppressive Agents in Dermatology

BioDrugs, 1997
Immune mechanisms play a central role in various diseases such as eczema and psoriasis, and in the past treatment tended to involve corticosteroids and cytostatic drugs. Organ transplantation has stimulated the development of newer immunosuppressants, some of which have also been found to be efficacious in the inflammatory dermatoses.
A I, Lauerma, H, Granlund, S, Reitamo
openaire   +2 more sources

A multi-agent architecture for teaching dermatology

Medical Informatics, 1998
This work proposes the integration of computer-aided instruction systems in the curricula of medical education, and describes an intelligent tutoring system used for teaching Dermatology. The Dermatology Tutor uses a self-organized society of autonomous software agents which have different capabilities or roles.
I D, Zaharakis, A D, Kameas, G C, Nikiforidis   +2 more
openaire   +2 more sources

Psychoactive Agents in Dermatology

2000
In dermatology, almost all diseases can benefit from use of psychoactive drugs, but, in our opinion, psychotropic agents are more commonly useful in: 1. Psychiatric syndromes with dermatological expression; in particular: Delusion of parasitosis Dermatitis artefacta Neurotic excoriations Trichotillomania Glossodynia ...
G. Hautmann, E. Panconesi
openaire   +1 more source

Evaluation of Retinoids as Therapeutic Agents in Dermatology

Pharmaceutical Research, 1994
Evaluation of 13-cis-12-substituted analogues of retinoic acid in a series of dermatologic screens has revealed that structural modifications can lead to selectivity and specificity. An analogue, 11-cis,13-cis-12-hydroxymethylretinoic acid, delta-lactone, has been found to have good activity and to be devoid of topical and systemic toxicity.
A H, Lewin, M E, Bos, F C, Zusi, X, Nair, G, Whiting, P, Bouquin, G, Tetrault, F I, Carroll   +7 more
openaire   +2 more sources

New antiviral agents for dermatologic disease

Seminars in Cutaneous Medicine and Surgery, 1998
The topic of antiviral agents for dermatologic disease is an area that is rapidly changing and expanding as our knowledge of herpes viruses, HIV, and human papilloma viruses continues to expand. New drugs are continuing to make therapy for these viruses more efficacious day by day.
S, Carlton, T, Evans, S K, Tyring
openaire   +2 more sources

Overview of biologic agents in medicine and dermatology

Seminars in Cutaneous Medicine and Surgery, 2005
Three agents have recently been approved by the Food and Drug Administration for the treatment of chronic plaque psoriasis: alefacept, efalizumab, and etanercept. The field of dermatology has now entered a new era, joining other disciplines of medicine that have been using biologic agents for decades.
openaire   +2 more sources

Cytotoxic agents for use in dermatology. I

Journal of the American Academy of Dermatology, 1985
There are indications for the use of cytotoxic drugs in some dermatologic diseases. These drugs may be lifesaving for patients with diseases such as pemphigus, lymphomas, and vasculitis or they may merely offer an improved quality of life for patients who have diseases such as psoriasis, progressive systemic sclerosis, or sarcoidosis.
openaire   +2 more sources

[Biological dermatologic agents. The Danish Society of Dermatology]

Ugeskrift for laeger, 2007
Udgivelsesdato: Mar ...
Iversen, Lars; id_orcid 0000-0003-1816-4508, Kragballe, Knud   +1 more
openaire   +3 more sources